CompaniesGQ Life Sciences

GQ Life Sciences

active

Alpharetta, GA, United States

Founded 2001

Website

About

Gene Patent Query Software

Areas of Focus

Categories

Southeastern U.S.

Clinical Trials (86)

View all

Total Trials

As Lead Sponsor

As Collaborator

Total Enrollment

21,196

By Phase

PHASE4: 8PHASE3: 23PHASE1: 29PHASE2: 8NA: 10PHASE2/PHASE3: 2PHASE1/PHASE2: 1

By Status

COMPLETED: 73UNKNOWN: 12TERMINATED: 1

Clinical Trials Pipeline86 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Today

NCT00600808

Sustained Release Formulation of Somatropin (rDNA Origin)for Injection

Phase: Phase 2/3

Role: Collaborator

Start: Jun 30, 2003

Completion: Jun 30, 2006

NCT00895596

Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B

Phase: Phase 1/2

Role: Lead Sponsor

Start: Mar 31, 2004

Completion: Dec 31, 2007

NCT00895596

NCT00271518

Treatment of Children With Insufficient Secretion of Growth Hormone

Phase: Phase 3

Role: Lead Sponsor

Start: Sep 30, 2005

Completion: Not specified

NCT00271518

NCT01879007

Phase I Trial for Pharmacokinetic Characteristics of Factive 200mg Intravenous Formulation (Gemifloxacin 200mg) With Factive 320mg Tablet Formulation (Gemifloxacin 320mg)

Phase: Phase 1

Role: Lead Sponsor

Start: Jan 31, 2006

Completion: Not specified

NCT01879007

NCT00294619

Treatment of Adults With Growth Hormone Deficiency

Phase: Phase 3

Role: Lead Sponsor

Start: Apr 30, 2006

Completion: Mar 31, 2008

NCT00596037

Treatment of Adults With Growth Hormone Deficiency

Phase: Phase 3

Role: Lead Sponsor

Start: Aug 31, 2006

Completion: May 31, 2009

NCT01019772

Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age

Phase: Phase 3

Role: Lead Sponsor

Start: Jul 31, 2007

Completion: Aug 31, 2008

NCT00776971

Effect of Carbonated Soft Drinks on Appetite-Regulation

Phase: N/A

Role: Collaborator

Start: Nov 30, 2007

Completion: Sep 30, 2008

NCT00777647

Effect of Carbonated Soft Drinks on the Body Weight

Phase: N/A

Role: Collaborator

Start: May 31, 2008

Completion: Dec 31, 2010

NCT01251133

Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study

Phase: Phase 3

Role: Lead Sponsor

Start: Jul 31, 2008

Completion: Mar 31, 2009

NCT03738020

Clinical Study to Evaluate the Correction of Wrinkles and Folds and Safety of YVOIRE Classic Versus Restylane in Nasolabial Fold Intradermal Injection

Phase: N/A

Role: Lead Sponsor

Start: Jan 31, 2009

Completion: Oct 31, 2009

NCT01001013

Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Subjects

Phase: Phase 1

Role: Lead Sponsor

Start: Feb 28, 2009

Completion: Dec 31, 2009

NCT01026610

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Phase: Phase 2

Role: Lead Sponsor

Start: Aug 31, 2009

Completion: May 31, 2011

NCT01896739

A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants

Phase: Phase 3

Role: Lead Sponsor

Start: Aug 31, 2009

Completion: Nov 30, 2011

NCT01122251

Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension

Phase: Phase 2

Role: Lead Sponsor

Start: Dec 31, 2009

Completion: Jul 31, 2010

NCT01601990

Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes

Phase: Phase 3

Role: Lead Sponsor

Start: Dec 31, 2009

Completion: Nov 30, 2011

NCT01602003

Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes

Phase: Phase 3

Role: Lead Sponsor

Start: Dec 31, 2009

Completion: May 31, 2012

NCT01605331

Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)

Phase: Phase 4

Role: Lead Sponsor

Start: Dec 31, 2009

Completion: Sep 30, 2010

NCT03738007

Clinical Study to Evaluate the Correction of Facial Wrinkles and Folds and Safety of YVOIRE Volume Versus Perlane in Nasolabial Fold Injection

Phase: N/A

Role: Lead Sponsor

Start: Mar 31, 2010

Completion: Dec 31, 2010

NCT02446353

Pharmacokinetics and Safety Study of Apetrol ES

Phase: Phase 1

Role: Lead Sponsor

Start: Apr 30, 2010

Completion: Oct 31, 2010

NCT01145950

Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®

Phase: Phase 1

Role: Lead Sponsor

Start: Jun 30, 2010

Completion: Jan 31, 2011

NCT01242787

Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Phase: Phase 2

Role: Lead Sponsor

Start: Aug 31, 2010

Completion: Sep 30, 2012

NCT01427868

Bioequivalence of LB80380 Free Base and Maleate Salt Tablets

Phase: Phase 1

Role: Lead Sponsor

Start: Sep 30, 2010

Completion: Dec 31, 2010

NCT01578304

Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder

Phase: Phase 4

Role: Lead Sponsor

Start: Dec 31, 2010

Completion: Oct 31, 2011

NCT01426906

Pharmacokinetic Drug Interaction Study in Healthy Male Subjects

Phase: Phase 1

Role: Lead Sponsor

Start: Jan 31, 2011

Completion: Mar 31, 2011

NCT01342055

Pharmacokinetics and Safety Study of Apetrol ES in Healthy Male Volunteers

Phase: Phase 1

Role: Lead Sponsor

Start: Mar 31, 2011

Completion: Aug 31, 2011

NCT01603238

Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] LC15-0444

Phase: Phase 1

Role: Lead Sponsor

Start: May 31, 2011

Completion: Jul 31, 2011

NCT01361646

Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189

Phase: Phase 1

Role: Lead Sponsor

Start: Jun 30, 2011

Completion: Jan 31, 2013

NCT01426399

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects

Phase: Phase 1

Role: Lead Sponsor

Start: Aug 31, 2011

Completion: Dec 31, 2011

NCT01659775

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)

Phase: Phase 4

Role: Lead Sponsor

Start: Aug 31, 2011

Completion: Nov 30, 2012

NCT01918709

Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers

Phase: Phase 1

Role: Lead Sponsor

Start: Sep 30, 2011

Completion: Nov 30, 2011

NCT01510535

Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis

Phase: Phase 3

Role: Lead Sponsor

Start: Dec 31, 2011

Completion: Oct 31, 2012

NCT01662687

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)

Phase: Phase 4

Role: Lead Sponsor

Start: Feb 29, 2012

Completion: Nov 30, 2012

NCT01526577

Study of LC23-1306 in Healthy Male Subjects

Phase: Phase 1

Role: Lead Sponsor

Start: Mar 31, 2012

Completion: Aug 31, 2013

NCT01624571

Study to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFRO

Phase: Phase 2

Role: Lead Sponsor

Start: Mar 31, 2012

Completion: Oct 31, 2012

NCT01918332

Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia

Phase: Phase 3

Role: Lead Sponsor

Start: Apr 30, 2012

Completion: Mar 31, 2013

NCT01928628

Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients

Phase: Phase 3

Role: Lead Sponsor

Start: May 31, 2012

Completion: Not specified

NCT01928628

NCT01586052

Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1

Phase: Phase 1

Role: Collaborator

Start: Jun 30, 2012

Completion: Oct 31, 2013

NCT01810900

To Assess the Anti-adhesive Effect and Safety of Protescal

Phase: Phase 3

Role: Lead Sponsor

Start: Sep 30, 2012

Completion: Dec 31, 2013

NCT01662674

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone

Phase: Phase 1

Role: Lead Sponsor

Start: Oct 31, 2012

Completion: Mar 31, 2013

NCT01725620

Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®

Phase: Phase 1

Role: Lead Sponsor

Start: Nov 30, 2012

Completion: Apr 30, 2014

NCT01737424

Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects

Phase: Phase 1

Role: Lead Sponsor

Start: Dec 31, 2012

Completion: Sep 30, 2013

NCT01918358

Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg

Phase: Phase 1

Role: Lead Sponsor

Start: Dec 31, 2012

Completion: Jan 31, 2013

NCT01747083

Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2tablets)

Phase: Phase 1

Role: Lead Sponsor

Start: Jan 31, 2013

Completion: Apr 30, 2013

NCT01768455

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects

Phase: Phase 1

Role: Lead Sponsor

Start: Feb 28, 2013

Completion: Not specified

NCT01768455

NCT01787396

Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d

Phase: Phase 3

Role: Lead Sponsor

Start: Apr 30, 2013

Completion: Mar 31, 2015

NCT01823133

Study for Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Rosuvastatin

Phase: Phase 1

Role: Lead Sponsor

Start: Apr 30, 2013

Completion: Aug 31, 2013

NCT01890629

Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)

Phase: Phase 4

Role: Lead Sponsor

Start: May 31, 2013

Completion: Aug 31, 2014

NCT02290301

An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin

Phase: N/A

Role: Lead Sponsor

Start: Jun 28, 2013

Completion: Nov 30, 2017

NCT02290301

NCT01825850

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects

Phase: Phase 1

Role: Lead Sponsor

Start: Jun 30, 2013

Completion: Mar 31, 2014

NCT02458768

Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.

Phase: Phase 4

Role: Lead Sponsor

Start: Jul 31, 2013

Completion: Not specified

NCT02458768

NCT02004587

Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White Volunteers

Phase: Phase 1

Role: Lead Sponsor

Start: Sep 30, 2013

Completion: Jul 31, 2014

NCT01968044

A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study)

Phase: Phase 3

Role: Lead Sponsor

Start: Oct 31, 2013

Completion: Oct 31, 2015

NCT01991145

Allogeneic UCB Therapy With EPO in Children With CP

Phase: N/A

Role: Collaborator

Start: Nov 26, 2013

Completion: Jun 24, 2017

NCT02340078

A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Volume Plus Versus YVOIRE Volume in Nasolabial Fold Injection

Phase: N/A

Role: Lead Sponsor

Start: Nov 30, 2013

Completion: Feb 28, 2015

NCT01990469

Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin

Phase: Phase 3

Role: Lead Sponsor

Start: Jan 31, 2014

Completion: Apr 30, 2015

NCT02070471

Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

Phase: Phase 2

Role: Lead Sponsor

Start: Jan 31, 2014

Completion: Not specified

NCT02070471

NCT02042170

Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients

Phase: Phase 2

Role: Lead Sponsor

Start: Feb 28, 2014

Completion: Mar 31, 2015

NCT02340091

A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Classic Plus Versus YVOIRE Classic in Nasolabial Fold Injection

Phase: N/A

Role: Lead Sponsor

Start: Feb 28, 2014

Completion: Jun 30, 2015

NCT02056600

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.

Phase: Phase 1

Role: Lead Sponsor

Start: Mar 31, 2014

Completion: May 31, 2014

NCT02122601

A Clinical Trial to Evaluate the Safety and Efficacy of Retreatment With Intra-articular LBSA0103 Injections in the Patients With Osteoarthritis of the Knee

Phase: Phase 3

Role: Lead Sponsor

Start: Apr 30, 2014

Completion: May 31, 2015

NCT02119780

Clinical Study to Evaluate the Efficacy and Safety of YVOIRE® Contour Compared With Restylane SubQ™ Injected Into the Anteromedial Malar Region

Phase: N/A

Role: Lead Sponsor

Start: May 31, 2014

Completion: Not specified

NCT02119780

NCT02126358

Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)

Phase: Phase 3

Role: Lead Sponsor

Start: May 31, 2014

Completion: Mar 31, 2016

NCT02089126

Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes

Phase: Phase 3

Role: Lead Sponsor

Start: Jun 30, 2014

Completion: Not specified

NCT02089126

NCT02204163

Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

Phase: Phase 3

Role: Lead Sponsor

Start: Jun 30, 2014

Completion: Dec 31, 2017

NCT02415192

Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

Phase: N/A

Role: Lead Sponsor

Start: Jul 31, 2014

Completion: Nov 30, 2016

NCT02186080

Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia

Phase: N/A

Role: Collaborator

Start: Jul 31, 2014

Completion: Jul 31, 2015

NCT02206867

Pharmacokinetics and Safety Study of LBAL in Healthy Subjects

Phase: Phase 1

Role: Lead Sponsor

Start: Aug 31, 2014

Completion: Feb 28, 2015

NCT02334358

Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s

Phase: N/A

Role: Lead Sponsor

Start: Sep 30, 2014

Completion: Aug 31, 2016

NCT01650415

Erythropoietin Therapy for Children With Cerebral Palsy

Phase: Phase 2

Role: Collaborator

Start: Sep 30, 2014

Completion: Dec 31, 2015

NCT01595880

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone

Phase: Phase 1

Role: Lead Sponsor

Start: Dec 31, 2014

Completion: Jan 31, 2015

NCT02250872

Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury

Phase: Phase 2/3

Role: Collaborator

Start: Dec 31, 2014

Completion: Jun 30, 2018

NCT02357069

A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Phase: Phase 3

Role: Lead Sponsor

Start: Feb 28, 2015

Completion: Not specified

NCT02357069

NCT02257645

Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks

Phase: N/A

Role: Lead Sponsor

Start: Mar 31, 2015

Completion: Sep 30, 2016

NCT02426151

Bioequivalence of a Single Subcutaneous Dose of BEPO and REPO in Healthy Male Subjects

Phase: Phase 1

Role: Lead Sponsor

Start: Apr 30, 2015

Completion: Sep 30, 2015

NCT02119793

Extension Clinical Study to Evaluate the Long-term Efficacy and Safety of Repeat Treatment of YVOIRE Contour Injected Into the Anteromedial Malar Region in Subjects Who Have Completed the LG-HACL014 Study

Phase: N/A

Role: Lead Sponsor

Start: May 31, 2015

Completion: Aug 31, 2016

NCT02661737

Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s

Phase: N/A

Role: Lead Sponsor

Start: May 31, 2015

Completion: Sep 30, 2017

NCT02670018

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone

Phase: Phase 1

Role: Lead Sponsor

Start: Aug 31, 2015

Completion: Mar 31, 2016

NCT02670070

BE Study of the Combinations of Gemigliptin 50mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone

Phase: Phase 1

Role: Lead Sponsor

Start: Mar 31, 2016

Completion: Jun 30, 2016

NCT02746380

A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Phase: Phase 3

Role: Lead Sponsor

Start: Apr 13, 2016

Completion: Feb 23, 2018

NCT02715908

A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX)

Phase: Phase 3

Role: Lead Sponsor

Start: Apr 30, 2016

Completion: Apr 30, 2018

NCT02770664

Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients

Phase: Phase 2

Role: Lead Sponsor

Start: Apr 30, 2016

Completion: Not specified

NCT02770664

NCT03015909

Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.

Phase: Phase 4

Role: Lead Sponsor

Start: Aug 11, 2016

Completion: Dec 21, 2017

NCT02892812

A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults

Phase: Phase 1

Role: Lead Sponsor

Start: Sep 30, 2016

Completion: Nov 30, 2016

NCT02831361

Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)

Phase: Phase 3

Role: Lead Sponsor

Start: Oct 17, 2016

Completion: Feb 8, 2018

NCT03051087

To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®

Phase: Phase 4

Role: Lead Sponsor

Start: Oct 31, 2016

Completion: Mar 31, 2018

Hover over trial bars to see details